510(k) K060204
K060204 is an FDA 510(k) premarket notification submitted by DiaSorin, Inc. for the device "LIAISON EA IGG". The FDA issued a decision of Substantially Equivalent on October 18, 2006. The device falls under product code LSE (Epstein-Barr Virus, Other), a Class I device regulated under 21 CFR 866.3235. DiaSorin, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 18, 2006
- Date Received
- January 26, 2006
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- Yes
Device Classification
- Device Name
- Epstein-Barr Virus, Other
- Device Class
- Class I
- Regulation Number
- 866.3235
- Review Panel
- MI
- Submission Type